Clinical Trial Update: Realizing Effectiveness Across Continents With Hydroxyurea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of hydroxyurea for sickle cell disease in children is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Disease, Children | Phase 2 | Status: ACTIVE_NOT_RECRUITING